Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2015-10-07

Clinical Trial Update: Quality Improvement Program (QIP) to Reduce 30-Day Readmission in Malnourished Hospitalized Patients

View source ↗

Summary

The Quality Improvement Program to reduce 30-day readmissions in malnourished hospitalized patients sponsored by Abbott Nutrition has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Abbott Nutrition | Conditions: Malnutrition | Status: TERMINATED